The first worldwide organization dedicated to mobile treatment of acute stroke has just elected its board of directors. One of those directors, Dr. Shazam Hussain, explains the group’s unique mission.
Patients with a history of intracranial hemorrhage have had few safe treatment options for nonvalvular atrial fibrillation. A new study of the Watchman device suggests that may be changing.
Mobile stroke units are gaining significant traction in the U.S. and around the world. A new paper looks back on the units’ time-to-treatment effects — and ahead to outcome and cost impacts.
Dr. Shazam Hussain recaps five developments at the 2018 International Stroke Conference that will shape cerebrovascular care for years to come.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Findings from the first study to examine the importance of treating in the “golden hour” specifically in the setting of ELVO strokes could reshape thinking around ELVO management.